Commitments and Contingencies (Tables)
|
12 Months Ended |
Sep. 30, 2022 |
Commitments and Contingencies Disclosure [Abstract] |
|
Schedule of exercisable share purchase warrants outstanding |
Schedule of exercisable share purchase warrants outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
Average |
|
|
Number of |
|
Exercise |
|
|
Shares |
|
Price ($) |
|
Balance, September 30, 2021 |
|
|
|
210,000 |
|
|
|
5.69 |
|
|
Forfeited |
|
|
|
(50,000 |
) |
|
|
12.00 |
|
|
Balance, September 30, 2022 |
|
|
|
160,000 |
|
|
|
3.72 |
|
|
Schedule of share purchase warrants outstanding |
Schedule of share purchase warrants outstanding |
|
|
|
|
|
|
|
|
Number |
|
Exercise Price |
|
Expiry Date |
|
150,000 |
|
|
$ |
3.17 |
|
|
May 6, 2024 |
|
10,000 |
|
|
$ |
12.00 |
|
|
April 21, 2026 |
|
160,000 |
|
|
|
|
|
|
|
|
Schedule of outstanding stock purchase options |
Schedule of outstanding stock purchase options | | | |
| | | |
| | | |
| | | |
| | |
| |
| |
Weighted | |
Weighted | |
|
| |
| |
Average | |
Average Grant | |
|
| |
Number of | |
Exercise Price | |
Date Fair Value | |
Aggregate |
| |
Shares | |
($) | |
($) | |
intrinsic value
($) |
| Outstanding,
September 30, 2021 | | |
| 11,330,903 | | |
| 5.74 | | |
| | | |
| 140,132,451 | |
| Granted | | |
| 2,358,000 | | |
| 10.13 | | |
| 7.07 | | |
| — | |
| Forfeited | | |
| (118,750 | ) | |
| 6.86 | | |
| 5.23 | | |
| — | |
| Exercised | | |
| (400,537 | ) | |
| 2.52 | | |
| 1.88 | | |
| 4,201,015 | |
| Outstanding,
September 30, 2022 | | |
| 13,169,616 | | |
| 6.61 | | |
| | | |
| 62,267,309 | |
| Exercisable,
September 30, 2022 | | |
| 8,777,113 | | |
| 4.40 | | |
| | | |
| 55,173,997 | |
|
Summarizes information about stock options |
Summarizes information about stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
average |
|
Weighted |
|
|
|
Weighted |
|
|
Number of |
|
remaining |
|
average |
|
|
|
average |
Range of exercise
prices |
|
outstanding |
|
contractual life |
|
exercise |
|
Number of |
|
exercise |
From |
|
To |
|
options |
|
(in years) |
|
price ($) |
|
vested options |
|
price ($) |
$ |
0.92 |
|
|
$ |
2.96 |
|
|
|
3,903,762 |
|
|
|
5.12 |
|
|
|
2.30 |
|
|
|
3,883,345 |
|
|
|
2.30 |
|
$ |
3.15 |
|
|
$ |
4.80 |
|
|
|
2,078,800 |
|
|
|
5.34 |
|
|
|
3.30 |
|
|
|
2,063,800 |
|
|
|
3.29 |
|
$ |
5.04 |
|
|
$ |
8.98 |
|
|
|
3,957,054 |
|
|
|
6.07 |
|
|
|
6.28 |
|
|
|
2,365,387 |
|
|
|
6.31 |
|
$ |
9.20 |
|
|
$ |
13.01 |
|
|
|
1,698,000 |
|
|
|
9.58 |
|
|
|
10.50 |
|
|
|
109,581 |
|
|
|
12.40 |
|
$ |
13.22 |
|
|
$ |
24.58 |
|
|
|
1,532,000 |
|
|
|
8.44 |
|
|
|
18.23 |
|
|
|
355,000 |
|
|
|
18.66 |
|
|
|
|
|
|
|
|
|
|
13,169,616 |
|
|
|
|
|
|
|
|
|
|
|
8,777,113 |
|
|
|
|
|
|
Schedule of general and administrative expenses and research and development expenses |
Schedule of general and administrative expenses and research and development expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
2021 |
|
2020 |
General and administrative |
|
$ |
7,129,412 |
|
|
$ |
3,571,335 |
|
|
$ |
2,210,789 |
|
Research and development |
|
|
11,249,830 |
|
|
|
4,660,068 |
|
|
|
2,666,117 |
|
Total stock-based compensation |
|
$ |
18,379,242 |
|
|
$ |
8,231,403 |
|
|
$ |
4,876,906 |
|
|
Schedule of weighted average assumptions for fair value of each option award |
Schedule of weighted average assumptions for fair value of each option award |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
2021 |
|
2020 |
Risk-free interest rate |
|
|
3.11 |
% |
|
|
0.73 |
% |
|
|
1.57 |
% |
Expected life of options (years) |
|
|
5.57 |
|
|
|
5.74 |
|
|
|
5.53 |
|
Annualized volatility |
|
|
84.17 |
% |
|
|
93.43 |
% |
|
|
95.99 |
% |
Dividend rate |
|
|
0.00 |
% |
|
|
0.00 |
% |
|
|
0.00 |
% |
|